Amgen — full event log
Every event we have on file across every reporting year. The Data-by-year tab summarises the top 10 per year; this page shows them all.
← back to Data by year2024· 14 events
Amgen has an SBTi-validated Scope 3 supplier target to engage 73% of suppliers by spend in key categories to support their adoption of science-based targets by 2027. Science-based goal setting has been embedded into sourcing criteria. Progress described as on track at end of 2024.
sustainability_report p.14
Achieve carbon neutrality for Amgen-owned and -operated facilities and operations by 2027 (Scope 1 and 2). At end of 2024, achieved 69% of targeted reduction vs 2019 baseline.
sustainability_report p.14
SBTi-validated Scope 3 supplier engagement target: engage with 73% of suppliers by spend in key categories to support their adoption of science-based targets by 2027. Science-based goal setting now part of sourcing criteria.
sustainability_report p.14
Reduce water consumption by 40% from 2019 baseline by 2027. Achieved 57% of targeted reduction in 2024.
sustainability_report p.14
Reduce waste disposed by 75% from 2019 baseline by 2027. Achieved 66% of targeted reduction in 2024.
sustainability_report p.14
In 2024, Amgen began augmenting its emission reduction project portfolio with high-quality Scope 1 carbon emission offsets — 40,000 MT included in 2024 Scope 1 figure of 107,000 MT. This is the first year offsets are baked into reported Scope 1.
sustainability_report p.15
Amgen increased EV adoption to 687 vehicles across the US, EU, Japan, Australia and South Korea in 2024, moving toward 1,800 EVs (30% of the total fleet) by 2027. In the US, Japan and EU, field-based employees must select all-electric or hybrid vehicles. 2024 fleet carbon emissions were 33% lower than the 2019 baseline.
sustainability_report p.14
At the Puerto Rico facility (Amgen's largest manufacturing site), process control optimisation reduced potable water consumption by 91,417 m³ in 2024. Across operations, 198,000 m³ of water-saving projects were executed and over 300 MT of waste-reduction projects implemented, even as total throughput grew with the operational footprint.
sustainability_report p.15
Amgen reports contributing to nine UN SDGs through core business and philanthropy: SDG 3 (Good Health), SDG 4 (Quality Education), SDG 5 (Gender Equality), SDG 6 (Clean Water), SDG 7 (Affordable Energy), SDG 8 (Decent Work), SDG 9 (Industry/Innovation), SDG 12 (Responsible Consumption), SDG 17 (Partnerships).
sustainability_report p.24
Achieved platinum-level TRUE Zero Waste Certification at San Francisco R&D facility — diverted >90% of nonhazardous waste from landfill/incineration. Over 105 MT diverted in 2024.
sustainability_report p.15
Amgen using initial gap analysis and ongoing alignment with the Taskforce for Nature-Related Financial Disclosures (TNFD) to shape local mitigation and conservation strategies. Identified proximity of largest sites to biodiversity hotspots and protected areas; collaborating with industry groups on supply chain biodiversity risks.
sustainability_report p.14
Amgen sourced 90% renewable electricity across its facilities in 2024. The new Ohio biomanufacturing site is the first fully electric Amgen facility, with an on-site solar array sized to generate 2,038 MWh annually delivered back to the local grid. The corporate aim is for all Amgen facilities, wherever feasible, to procure 100% renewable energy by 2027. Purchased renewable energy rose from 480,000 GJ in 2019 to 1,210,000 GJ in 2024, while purchased fossil energy dropped from 975,000 to 132,000 GJ over the same period.
sustainability_report p.15
In 2024 Amgen began augmenting its innovative and energy-efficient project portfolio with high-quality Scope 1 carbon emission offsets to assist progress toward its 2027 carbon neutrality ambition. 40,000 MT of high-quality carbon offsets were included in the 2024 Scope 1 figure. Amgen describes them as 'offsets' rather than removals and does not distinguish durable removals (DAC, BECCS, biochar) from avoidance credits.
sustainability_report p.15
Amgen's proprietary Ecovation™ biomanufacturing approach uses flexible, modular designs that require less space, are built faster, cost less to operate, and have lower environmental impact than traditional plants. The new Ohio facility is fully electric and the North Carolina facility achieved Fitwel certification. These plants are central to delivering the 2027 Scope 1+2 carbon neutrality target.
sustainability_report p.15
2023· 2 events
In 2023, Amgen restated collisions per million miles (CPMM) data for 2021 and beyond to use business miles only (previously included personal + business). 2019 and 2020 use the previous methodology.
sustainability_report p.19
Amgen acquired Horizon Therapeutics on October 6, 2023. The 2023 and 2024 financial data include this acquisition. Legacy Horizon employees were excluded from the 2024 pay study.
sustainability_report p.20